603717 天域生物
按盤價 
6.620 +0.050 (+0.761%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -14.476 | -22.961 | -18.440 | -52.666 | -24.726 |
| 總資產報酬率 ROA (%) | -1.892 | -3.500 | -3.310 | -13.779 | -9.241 |
| 投入資產回報率 ROIC (%) | -3.124 | -5.550 | -4.988 | -20.336 | -13.355 | 邊際利潤分析 |
| 銷售毛利率 (%) | -0.966 | -0.125 | 10.833 | -34.418 | 11.326 |
| 營業利潤率 (%) | -14.571 | -14.045 | -11.188 | -84.931 | -34.186 |
| 息稅前利潤/營業總收入 (%) | -13.067 | -12.013 | -9.631 | -83.382 | -31.980 |
| 淨利潤/營業總收入 (%) | -14.718 | -14.060 | -10.835 | -84.404 | -28.415 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.906 | 114.583 | 53.412 | 62.389 | 9.504 |
| 價值變動淨收益/利潤總額(%) | -22.849 | -4.696 | 0.245 | 6.237 | -0.582 |
| 營業外收支淨額/利潤總額(%) | -4.177 | -5.899 | -2.883 | 1.583 | -1.968 | 償債能力分析 |
| 流動比率 (X) | 0.899 | 0.850 | 1.079 | 1.314 | 1.693 |
| 速動比率 (X) | 0.723 | 0.680 | 0.913 | 1.186 | 1.481 |
| 資產負債率 (%) | 80.987 | 79.481 | 77.962 | 74.505 | 59.130 |
| 帶息債務/全部投入資本 (%) | 61.223 | 60.342 | 55.968 | 50.309 | 42.066 |
| 股東權益/帶息債務 (%) | 31.965 | 39.049 | 44.097 | 58.272 | 112.619 |
| 股東權益/負債合計 (%) | 14.651 | 17.935 | 20.696 | 26.480 | 54.637 |
| 利息保障倍數 (X) | -14.214 | -9.616 | -7.744 | -28.604 | -20.685 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 178.892 | 171.278 | 173.209 | 229.198 | 198.575 |
| 存貨周轉天數 (天) | 115.006 | 111.117 | 96.562 | 79.767 | 74.263 |
| 備註： | 即時報價更新時間為 28/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
